Polycystic ovary syndrome: a risk factor for cardiovascular disease? (Q33823437)

29 July 2017

1 reference

title

Polycystic ovary syndrome: a risk factor for cardiovascular disease? (English)

1 reference

polycystic ovary syndrome

29 July 2017

0 references

1 reference

1 reference

1 reference

Rajkhowa M

1

1 reference

29 July 2017

Glass MR

2

1 reference

29 July 2017

Rutherford AJ

3

1 reference

29 July 2017

Michelmore K

4

1 reference

29 July 2017

Balen AH

5

1 reference

29 July 2017

1 January 2000

1 reference

BJOG: an International Journal of Obstetrics and Gynaecology

29 July 2017

1 reference

29 July 2017

107

1 reference

29 July 2017

1

1 reference

29 July 2017

11-18

1 reference

The effects of ovulation induction with gonadotrophins on the ovary and uterus and implications for assisted reproduction

29 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Polycystic ovaries--a common finding in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Insulin resistance and risk factors for coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Coronary heart disease risk factors in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Ultrasonic evaluation of early carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-0528.2000.TB11572.X

10.1111/J.1471-0528.2000.TB11572.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference